Metoprolol vs. propranolol
Title: Metoprolol vs. propranololCategory: MedicationsCreated: 5/13/2019 12:00:00 AMLast Editorial Review: 5/13/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 13, 2019 Category: Drugs & Pharmacology Source Type: news

Metoprolol vs. labetalol
Title: Metoprolol vs. labetalolCategory: MedicationsCreated: 5/13/2019 12:00:00 AMLast Editorial Review: 5/13/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 13, 2019 Category: Drugs & Pharmacology Source Type: news

Metoprolol vs. clonidine
Title: Metoprolol vs. clonidineCategory: MedicationsCreated: 5/9/2019 12:00:00 AMLast Editorial Review: 5/9/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 9, 2019 Category: Drugs & Pharmacology Source Type: news

Metoprolol vs. diltiazem
Title: Metoprolol vs. diltiazemCategory: MedicationsCreated: 5/9/2019 12:00:00 AMLast Editorial Review: 5/9/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 9, 2019 Category: Drugs & Pharmacology Source Type: news

Metoprolol vs. atenolol
Title: Metoprolol vs. atenololCategory: MedicationsCreated: 5/8/2019 12:00:00 AMLast Editorial Review: 5/8/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 8, 2019 Category: Drugs & Pharmacology Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news

Metoprolol Tartrate Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 16, 2019 Category: Drugs & Pharmacology Source Type: news

Metoprolol Tartrate Injection, USP (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 2, 2019 Category: Drugs & Pharmacology Source Type: news

Ongoing supply issues with Metoprolol 50mg and 100mg tablets
ongoing supply issues withMetoprolol 50mg and 100mg tablets... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 27, 2019 Category: Drugs & Pharmacology Source Type: news

Ongoing medicine supply issues with Metoprolol 50mg and 100mg tablets
ongoing supply issues withMetoprolol 50mg and 100mg tablets... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 27, 2019 Category: Drugs & Pharmacology Source Type: news

Beta blockers: Do they cause weight gain?
Yes. Weight gain can occur as a side effect of some beta blockers, especially the older ones, such as atenolol (Tenormin) and metoprolol (Lopressor, Toprol-XL). The average weight gain is about 2.6 pounds (about 1.2 kilograms). Newer beta blockers, such as carvedilol (Coreg), don't usually cause weight gain as a side effect. Weight may rise [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 19, 2019 Category: Databases & Libraries Source Type: news

EU's Tainted-Sartan Ban; Praluent Price Cut; Metoprolol Shortage Relieved?
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 11, 2019 Category: Cardiology Source Type: news

Affiliate of Charlotte-based Premier partners with Baxter to make generic drugs more available
ProvideGx, a subsidiary of Charlotte-based Premier Inc. (NASDAQ: PINC), is partnering with Baxter Healthcare Corp. to make generic drugs more readily available. The partnership will provide a better supply line for metoprolol, a blood pressure medication. Health-care providers have experienced metoprolol shortages since 2016, and by identifying it as an essential medication, Baxter and Premier hope to make it more available to providers at competitive pri ces, according to a press release. Financial… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2019 Category: Pharmaceuticals Authors: Caroline Hudson Source Type: news

Medical News Today: Metoprolol tartrate vs. metoprolol succinate
Metoprolol tartrate and metoprolol succinate are different salt forms of metoprolol. Both drugs are beta-blockers that doctors prescribe to treat several cardiovascular conditions. However, despite being similar, they do have some different uses. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 14, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Medical News Today: All you need to know about metoprolol
Metoprolol is a beta-blocker that doctors often prescribe to treat cardiovascular issues, such as high blood pressure and angina. Different types of metoprolol have different uses. Learn more about how this drug works, when a doctor may prescribe it, and what the potential side effects can be here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 18, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Kapspargo Sprinkle (Metoprolol Succinate Capsules ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 14, 2018 Category: Drugs & Pharmacology Source Type: news

Cipla gets USFDA nod for hypertension, cardiac drug
Cipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina Pectoris (chest pain or discomfort due to coronary heart disease). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 29, 2018 Category: Pharmaceuticals Source Type: news

Colorado biotech reports drug test results; shares nosedive
A Westminster biopharmaceutical announced the results of a test of its drug treatment for atrial fibrillation and its shares were plummeting early Monday. Arca Biopharma Inc. (Nasdaq: ABIO) released the results of a test of its Gencaro treatment for cardiovascular disease. In early Monday trading, its shares were down more than 58 percent, falling 94 cents to 66 cents. The drug test involved 267 patients who were given either an active control, met oprolol succinate (Toprol-XL) or Gencaro. "In… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 26, 2018 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Coreg vs. Metoprolol Tartrate
Title: Coreg vs. Metoprolol TartrateCategory: MedicationsCreated: 12/18/2017 12:00:00 AMLast Editorial Review: 12/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 18, 2017 Category: Drugs & Pharmacology Source Type: news

Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone − a first pediatric case report - Kacirova I, Grundmann M, Kolek M, Vyskocilova-Hrudikova E, Urinovska R, Handlos P.
We present a pediatric case... (Source: SafetyLit)
Source: SafetyLit - July 7, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

AstraZeneca signs deal to sell commercial rights for Seloken in Europe
AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments i … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 23, 2017 Category: Pharmaceuticals Source Type: news

AstraZeneca enters agreement with Recordati for Seloken in Europe
AstraZeneca announced today that it has entered into an agreement with Recordati S.p.A (Recordati) for the commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments in Europe. (Source: World Pharma News)
Source: World Pharma News - May 22, 2017 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

How Metoprolol Reduces Infarct Size: Simply'Stunning'How Metoprolol Reduces Infarct Size: Simply'Stunning '
The beta-blocker, given early after MI onset, is cardioprotective at least partly due to an anti-inflammatory neutrophil-stunning effect, say researchers; implications may go beyond acute MI therapy.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Scientists discover how a decades-old drug reduces the size of a heart attack
Scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have discovered a new mechanism of action of metoprolol, a drug that can reduce the damage produced during a heart attack if administered early. The team led by Dr. Borja Ibáñez, Clinical Research Director at the CNIC and cardiologist at the Fundación Jiménez Díaz University Hospital Health Research Institute (IIS-FJD), has identified the mechanism that explains why this drug is so beneficial: rapid administration of metoprolol during a heart attack directly inhibits the inflammatory action of neutroph...
Source: World Pharma News - April 18, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

CNIC scientists discover how a decades-old drug reduces the size of a heart attack
(Centro Nacional de Investigaciones Cardiovasculares) The beta-blocker metoprolol can limit cardiac damage in patients having a heart attack. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 18, 2017 Category: Global & Universal Source Type: news

Make the Diagnosis: Guess the Vessel
(MedPage Today) -- Case Findings: A 50-year old male with family history significant for premature CAD presents with chest pain which started 3 hours ago. Blood pressure 150/90 mm Hg, HR 60/min. EKG in the emergency department is shown (see image below). Successful intervention of the culprit coronary artery is performed with one drug eluting stent. He is started on aspirin, ticagrelor, atorvastatin and metoprolol. Next morning he is found to be hypotensive to SBP 90s. Hemoglobin, creatinine and electrolytes are normal. Right groin access site is without any hematoma. A stat bedside echocardiogram reveals ejection fraction...
Source: MedPage Today Cardiovascular - January 30, 2017 Category: Cardiology Source Type: news

Patient With Chest Pain and Shortness of Breath Shows Standardized Treatment Doesn't Work for All Patients
John, a 65-year-old male, is sitting in a chair in the corner of the room as you and your partner enter his house. John tells you he's the only one home and called 9-1-1 because he can't breathe and his chest is killing him. His skin is ashen and his breathing is rapid. You can palpate a weak irregular pulse and you note his skin is warm and diaphoretic. He describes his shortness of breath as increasing in severity over the last couple of hours with the chest discomfort. With a pulse oximetry reading of 78% on room air, you apply oxygen via a non-rebreathing mask. Physical exam reveals bibasilar crackles on pulmonary ausc...
Source: JEMS Patient Care - December 30, 2016 Category: Emergency Medicine Authors: Dennis Edgerly, EMT-P Tags: Columns Patient Care Source Type: news

Lopressor HCT (Metoprolol Tartrate and Hydochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 6, 2016 Category: Drugs & Pharmacology Source Type: news

Lopressor Injection (Metoprolol Tartrate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 6, 2016 Category: Drugs & Pharmacology Source Type: news

metoprolol (Lopressor, Toprol XL)
Title: metoprolol (Lopressor, Toprol XL)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/1/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 1, 2016 Category: Cardiology Source Type: news

Sun Pharma strikes distribution alliance with Mitsubishi Tanabe in Japan
Sun ’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2016 Category: Pharmaceuticals Source Type: news

Toprol XL (Metoprolol Succinate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 2, 2016 Category: Drugs & Pharmacology Source Type: news

Lopressor (Metoprolol Tartrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 1, 2016 Category: Drugs & Pharmacology Source Type: news

Make the Diagnosis: Puzzling Palpitations
(MedPage Today) -- Case Findings: A 44-year-old male presents with palpitations of 3 months'duration. At first they were occasional and occurred about twice a week. However, they have increased over time with frequency up almost hourly. He has noticed a recent 10-pound weight gain, increased lower extremity swelling, and inability to lie flat. He denies any fevers or chills. His last exercise stress test 5 months ago was normal. His current medications include metoprolol 12.5 mg twice daily, lisinopril 10 mg daily, aspirin 81 mg daily, furosemide 40 mg daily. There have been no recent readjustments in his medical regimen. ...
Source: MedPage Today Cardiovascular - August 30, 2016 Category: Cardiology Source Type: news

Do Angioplasty Patients Really Need Beta-Blocker Drugs?
TUESDAY, Aug. 16, 2016 -- Doctors might be overprescribing beta-blocker medications to heart patients who aren't seriously ill, a new study contends. Beta blockers such as Inderal (propranolol) and Lopressor (metoprolol) reduce blood pressure and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 16, 2016 Category: Journals (General) Source Type: news

Make the Diagnosis: Dizziness Dilemma
(MedPage Today) -- Case Findings: A 42-year-old African American male presents with a report of dizziness and lightheadedness 3 days ago when he was standing up to go to the rest room. He denies any syncopal episodes. He has medically managed hypertension, hypercholesterolemia, and cardiomyopathy, and a last ejection fraction of 35% with defibrillator placement 4 months ago. His AICD did not fire during the dizziness episode. His last cardiac catheterization prior to AICD implantation revealed normal coronaries. The patient has been compliant with metoprolol 25 mg twice daily, lisinopril 10 mg daily, atorvastatin 40 mg dai...
Source: MedPage Today Cardiovascular - August 10, 2016 Category: Cardiology Source Type: news

Do you know the answer to this tough USMLE Step 2 question?
If you’re gearing up to take the United States Medical Licensing Examination® (USMLE®) Step 2, get this month’s exclusive scoop on the most missed USMLE Step 2 test prep question and expert strategies to help you master it. Think you have what it takes to rise above your peers? Test your USMLE knowledge, and view an expert video explanation of the answer from Kaplan Medical. Once you’ve got this question under your belt, be sure to test your knowledge with other posts in this series. Ready. Set. Go. This month’s question that stumped most students: A 57-year-old female with a his...
Source: AMA Wire - April 28, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news

Make the Diagnosis: Dizziness Dilemma
(MedPage Today) -- Case Findings: The patient is a 42-year-old African American man who presents with a complaint of dizziness lightheadedness which occurred when he was standing up to go to the rest room 3 days ago. He denies any previous syncopal episodes. He has medically managed hypertension, hypercholesterolemia, cardiomyopathy with last ejection fraction of 35% with defibrillator placement 4 months previous. His ICD did not fire during the episode. His last cardiac catheterization prior to ICD implantation revealed normal coronaries. Patient has been compliant with metoprolol 25 mg twice daily, lisinopril 10 mg daily...
Source: MedPage Today Endocrinology - April 26, 2016 Category: Endocrinology Source Type: news

ACC: No Benefit for Beta-Blocker Before PCI
(MedPage Today) -- IV metoprolol was safe, but disappointing (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 5, 2016 Category: Cardiology Source Type: news

Studying for USMLE Step 2? Master this most missed question
Studying for the United States Medical Licensing Examination® (USMLE®) Step 2 may seem daunting, but not to fear. Starting this month, we’re giving you an exclusive scoop on the most missed USMLE Step 2 test prep questions and expert strategies to help you beat them. Check out this month’s most challenging question, and view an expert video explanation of the answer from Kaplan Medical. Welcome to the first Step 2 post in AMA Wire’s® series, “Tutor talk: Tips from Kaplan Medical on the most missed USMLE test prep questions from Kaplan’s Qbank.” Each month, we’re ...
Source: AMA Wire - February 24, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news

Metoprolol Injection (Updated - Currently in Shortage)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 26, 2016 Category: Drugs & Pharmacology Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Patient Care - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Special Topics - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

Metoprolol Injection (Updated - Currently in Shortage)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - January 5, 2016 Category: Drugs & Pharmacology Source Type: news

Lopressor Injection (Metoprolol Tartrate Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 21, 2015 Category: Drugs & Pharmacology Source Type: news

Candesartan May Cut Cardiotoxicity in Breast Cancer PatientsCandesartan May Cut Cardiotoxicity in Breast Cancer Patients
Adjuvant candesartan (but not metoprolol) showed "significant but modest" attenuation of LVEF changes after cancer therapy. More research is needed, but "this study is a key first step," notes one expert. Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 12, 2015 Category: Cardiology Tags: Cardiology News Source Type: news